Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-25-000192
Filing Date
2025-05-06
Accepted
2025-05-06 16:04:39
Documents
87
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20250331.htm   iXBRL 10-Q 1243549
2 EX-10.1 a2025q110-qexhibit101.htm EX-10.1 67624
3 EX-31.1 a2025q110-qexhibit311.htm EX-31.1 10725
4 EX-31.2 a2025q110-qexhibit312.htm EX-31.2 10723
5 EX-32.1 a2025q110-qexhibit321.htm EX-32.1 6297
11 GRAPHIC vrtx-20250331_g1.jpg GRAPHIC 39966
  Complete submission text file 0000875320-25-000192.txt   7910297

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20250331.xsd EX-101.SCH 46204
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20250331_cal.xml EX-101.CAL 98059
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20250331_def.xml EX-101.DEF 269445
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20250331_lab.xml EX-101.LAB 625735
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20250331_pre.xml EX-101.PRE 470363
90 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20250331_htm.xml XML 1280183
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 25917162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)